← All diseases
Brain and nervous system
Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications and studies (1195)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity (2025-05-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Mobility in Atypical Parkinsonism: a Trial of Physiotherapy (2025-05-16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 4 Repeat Tauopathy Neuroimaging Initiative (2025-05-08) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. AI-Enhanced Optimization of Acute Levodopa Challenge Test (2025-04-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2 (2025-04-13) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases (2025-04-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Diagnosing Frontotemporal Lobar Degeneration (2025-03-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Personalized Parkinson Project PSP Cohort (2025-03-24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP (2025-03-17) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely (2025-03-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. NYSCF Scientific Discovery Biobank (2025-03-03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of [18F]APN-1607 as a PET Biomarker (2025-02-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism (2025-01-10) ♡
- Transdiagnostic Network Localization of Social, Language, and Motor Symptoms in Patients With Frontotemporal Lobar Degeneration. (2024/12/24) ♡
- Differentiating atypical parkinsonian syndromes with hyperbolic few-shot contrastive learning. (2024/12/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diagnosing primary lateral sclerosis: a clinico-pathological study. (2024/12/12) ♡
- Current Landscape of Clinical Diagnosis in Multiple System Atrophy: A 15-Year Analysis From 2008 to 2022. (2024/12/10) ♡
- FTLD-MAPT mutations and short 5'UTR Tau mRNAs increase Tau translation. (2024/12/10) ♡
- Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy. (2024/12/09) ♡
- Possible Impact of Peripheral Inflammatory Factors and Interleukin-1β (IL-1β) on Cognitive Functioning in Progressive Supranuclear Palsy-Richardson Syndrome (PSP-RS) and Progressive Supranuclear Palsy-Predominant Parkinsonism (PSP-P). (2024/12/09) ♡
- Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study. (2024/12/05) ♡
- Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis. (2024/12/04) ♡
- Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy. (2024/12/04) ♡
- Spatial discrimination in patients with MSA, PSP, DIP, and VP with pain. (2024/12/02) ♡
- Monocyte to high-density lipoprotein cholesterol ratio reflects the peripheral inflammatory state in parkinsonian disorders. (2024/12/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Combinations of physical and cognitive training for subcortical neurodegenerative diseases with physical, cognitive and behavioral symptoms: a systematic review. (2024/12/01) ♡
- Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy. (2024/12/01) ♡
- Microscopy assessment of a fluorescence [(18)F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions. (2024/12/01) ♡
- Development of a novel radioiodinated compound for amyloid and tau deposition imaging in Alzheimer's disease and tauopathy mouse models. (2024/12/01) ♡
- Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series. (2024/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment. (2024/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. FDA Boosts the Progressive Supranuclear Palsy Rating Scale! (2024/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP-NET". (2024/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP-NET. (2024/12/01) ♡
- The Effect of Alcohol Consumption on Progressive Supranuclear Palsy: A Cross-Sectional Study. (2024/12/01) ♡
- Seeding activity of skin misfolded tau as a biomarker for tauopathies. (2024/11/29) ♡
- Lexical markers of disordered speech in primary progressive aphasia and 'Parkinson-plus' disorders. (2024/11/29) ♡
- Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies. (2024/11/24) ♡
- Diffusion tensor imaging along the perivascular space: the bias from crossing fibres. (2024/11/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders. (2024/11/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Quality of life in patients with progressive supranuclear palsy: a review of literature and implications for practice. (2024/11/20) ♡
- Comparison of MIBG uptake in the major salivary glands between Lewy body disease and progressive supranuclear palsy. (2024/11/20) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The Gunslinger's sign in atypical parkinsonism. (2024/11/15) ♡
- Dysphagia in progressive supranuclear palsy: A scoping review. (2024/11/15) ♡
- Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes. (2024/11/13) ♡
- Corrigendum: An automatic measure for speech intelligibility in dysarthrias-validation across multiple languages and neurological disorders. (2024/11/13) ♡
- Erythrocytic α-Synuclein in Parkinson's Disease and Progressive Supranuclear Palsy-A Pilot Study. (2024/11/02) ♡
- Clinical prognostic factors in progressive supranuclear palsy: Implications for clinical trials. (2024/11/01) ♡
- Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation. (2024/10/30) ♡
- Proximity Elongation Assay and ELISA for the Identification of Serum Diagnostic Biomarkers in Parkinson's Disease and Progressive Supranuclear Palsy. (2024/10/30) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.